These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7357810)

  • 21. Propoxyphene and norpropoxyphene: pharmacologic and toxic effects in animals.
    Nickander R; Smits SE; Steinberg MI
    J Pharmacol Exp Ther; 1977 Jan; 200(1):245-53. PubMed ID: 13200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute poisoning with dextropropoxyphene. Clinical symptoms and plasma concentrations.
    Gustafson A; Gustafsson B
    Acta Med Scand; 1976; 200(4):241-8. PubMed ID: 983792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquid chromatographic determination of propoxyphene and norpropoxyphene in plasma and breast milk.
    Kunka RL; Yong CL; Ladik CF; Bates TR
    J Pharm Sci; 1985 Jan; 74(1):103-4. PubMed ID: 3981406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitation of propoxyphene and its major metabolites in heroin addict plasma after large dose administration of propoxyphene napsylate.
    Nash JF; Bennett IF; Bopp RJ; Brunson MK; Sullivan HR
    J Pharm Sci; 1975 Mar; 64(3):429-33. PubMed ID: 1151627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unstable propoxyphene metabolite excreted in human urine is detected by liquid chromatography-tandem mass spectrometry.
    Crews B; Mikel C; Latyshev S; West R; Pesce A
    J Anal Toxicol; 2009 Sep; 33(7):379-83. PubMed ID: 19796508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propoxyphene and norpropoxyphene: influence of type of controlled-release formulation on intra- and intersubject variations.
    Bechgaard H; Baggesen S
    J Pharm Sci; 1980 Nov; 69(11):1327-30. PubMed ID: 7452465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propoxyphene-induced hypoglycemia in a patient with chronic renal failure.
    Almirall J; Montoliu J; Torras A; Revert L
    Nephron; 1989; 53(3):273-5. PubMed ID: 2797348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of new d-propoxyphene derivatives and the development of a microparticle-based immunoassay for the detection of propoxyphene and norpropoxyphene.
    Wu RS; McNally AJ; Pilcher IA; Salamone SJ; Rashid S
    Bioconjug Chem; 1997; 8(3):385-90. PubMed ID: 9177845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GLC determination of paracetamol and d-propoxyphene.
    Serfontein WJ; de Villiere LS; Villiers LS; Botha D
    S Afr J Med Sci; 1976; 41(4):297-304. PubMed ID: 1019754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro metabolism of propoxyphene in rat liver: reaction of a carbinol metabolite with acetaldehyde.
    Hermansson I; Hermansson J; Stjernström NE
    Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):257-64. PubMed ID: 6650176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propoxyphene and norpropoxyphene quantitation in the same solid-phase extraction using Toxi-Lab Spec VC MP3 system.
    King JW; King LJ
    J Anal Toxicol; 1994; 18(4):217-9. PubMed ID: 7967543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of propoxyphene bioavailability by ethanol. Relation to psychomotor and cognitive function in healthy volunteers.
    Girre C; Hirschhorn M; Bertaux L; Palombo S; Dellatolas F; Ngo R; Moreno M; Fournier PE
    Eur J Clin Pharmacol; 1991; 41(2):147-52. PubMed ID: 1743247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute effect of ethanol on hepatic first-pass elimination of propoxyphene in rats.
    Oguma T; Levy G
    J Pharmacol Exp Ther; 1981 Oct; 219(1):7-13. PubMed ID: 7288618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic interaction of propoxyphene with ethanol.
    Sellers EM; Hamilton CA; Kaplan HL; Degani NC; Foltz RL
    Br J Clin Pharmacol; 1985 Mar; 19(3):398-401. PubMed ID: 3986091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excretion of propoxyphene and norpropoxyphene in breast milk.
    Kunka RL; Venkataramanan R; Stern RM; Ladik CF
    Clin Pharmacol Ther; 1984 May; 35(5):675-80. PubMed ID: 6713779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
    Olszewska M
    Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethanol does not increase lethality due to propoxyphene in rats.
    Bodd E; Olsen H; Gulliksen M; Mørland J
    Alcohol; 1985; 2(2):293-6. PubMed ID: 4015849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitation of plasma levels of propoxyphene and norpropoxyphene by combined use of stable isotope labeling and selected ion monitoring.
    Sullivan HR; Emmerson JL; Marshall FK; Wood PG; McMahon RE
    Drug Metab Dispos; 1974; 2(6):526-32. PubMed ID: 4155676
    [No Abstract]   [Full Text] [Related]  

  • 40. The simultaneous determination of propoxyphene and norpropoxyphene in human biofluids using gas-liquid chromatography.
    Verebely K; Inturrisi CE
    J Chromatogr; 1973 Jan; 75(2):195-205. PubMed ID: 4701539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.